60 Degrees Pharmaceuticals (SCTP) Proxy Filing summary

Executive summary

• The annual meeting will be held virtually on October 8, 2025, with voting available by phone or mail for shareholders of record as of August 26, 2025.

• Key proposals include director elections, amendments to the equity incentive plan, a reverse stock split, auditor ratification, and potential adjournment to solicit more proxies.

• Proxy materials are distributed primarily online to expedite delivery, reduce costs, and conserve resources.

Voting matters and shareholder proposals

• Shareholders will vote on electing five directors, increasing shares under the 2022 Equity Incentive Plan by 250,000, approving a reverse stock split (1:3 to 1:10), ratifying RBSM LLP as auditor, and adjourning the meeting if needed.

• The board recommends voting FOR all proposals.

• No other business is expected, and no shareholder proposals or nominations were received for this meeting.

Board of directors and corporate governance

• The board consists of five directors, three of whom are independent under Nasdaq rules.

• Board committees include Audit, Compensation, and Nominating and Corporate Governance, each with defined charters and responsibilities.

• Directors are elected annually, and the board met five times in 2024, with high attendance.

• The company maintains a code of conduct and emphasizes diversity and integrity in board selection.